Trial Profile
A phase I study of naproxen formulated using SoluMatrix technology
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2011
Price :
$35
*
At a glance
- Drugs Naproxen (Primary)
- Indications Pain; Rheumatic disorders
- Focus Pharmacokinetics
- Sponsors Iroko Pharmaceuticals
- 10 Jan 2011 New trial record